Try our Advanced Search for more refined results
April 15, 2016
AbbVie Inc. et al v. MedImmune, LLC
Case Number:
8:16-cv-01129
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 15, 2016
AbbVie Wants MedImmune's Humira Patent Invalidated
AbbVie Inc. filed a suit Friday in Maryland federal court seeking to invalidate a patent held by MedImmune LLC covering AbbVie's blockbuster arthritis drug Humira, saying the patent is invalid under the doctrine barring double patenting.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login